Cordella Pulmonary Artery Sensor System (CorPASS)
Endotronix, Inc. · Decision date Oct 20, 2026
What did the FDA decide?
The FDA recorded decision OK30 on 2026-10-20 for P230040/S035, a 30-Day Notice supplement to the Cordella Pulmonary Artery Sensor System (CorPASS) held by Endotronix, Inc. The supplement falls under the process change category for manufacturer, sterilizer, packager or supplier. The stated scope is removal of a redundant inspection process of the Coil PCB subassemblies. The device is listed in the implantable hemodynamic system category under the Cardiovascular specialty with product code MOM.
This action covers a manufacturing process change for a named subassembly rather than a new approval of the whole CorPASS system. The source record does not describe the inspection method removed, the rationale for treating it as redundant, or any verification data supporting the change; those details would sit in the supplement submission, which is not included here. No clinical, efficacy or patient-selection conclusions follow from this record, and the source gives no information on current labeling or post-change performance.
FDA approval order statement
removal of a redundant inspection process of the Coil PCB subassemblies
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 20, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P230040/S035
- Regulatory pathway
- PMA supplement
- Applicant
- Endotronix, Inc.
- Product code
- MOM
- Decision code
- OK30
- Decision date
- Oct 20, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, hemodynamic, implantable.
- Applicant
- Endotronix, Inc.
- Product code
- MOM
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P230040. Subsequent supplements may change the device or its indications.
FDA decision timeline
P230040 · Original PMA
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S035 received
Application receipt date recorded by FDA.
P230040/S033 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S034 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S031 · Related supplement
Cordelia Pulmonary Artery Pressure Sensor System (CorPASS)
P230040/S035 · FDA decision
30-Day Notice
P230040/S030 · Related supplement
Cordella Pulmonary Artery Sensor System
Timeline entries are records held by MedtechLedger for P230040. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P230040
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Endotronix, Inc. | PMA approval | Jun 20, 2024 | FDA | |
| Endotronix, Inc. | PMA supplement | Sep 25, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Oct 14, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
Cordella Pulmonary Artery Sensor SystemP230040/S030 | Endotronix, Inc. | PMA supplement | Oct 29, 2026 | FDA |
Explore the linked device profile
Other records with product code MOM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Sep 30, 2026 | FDA | |
CardioMEMS PA Sensor and Delivery SystemP100045/S093 | ABBOTT MEDICAL | PMA supplement | Sep 30, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 11, 2026 | FDA | |
| ABBOTT MEDICAL | PMA approval | May 28, 2014 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Endotronix, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1415 W. Diehl Rd., Suite 500w, Naperville, IL, 60563
Sources and methodology
- Original FDA record: P230040/S035
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



